- Home
- NNBR vs SGMO Comparison
NNBR vs SGMO Comparison
Compare NNBR & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNBR
- SGMO
- Stock Information
- Founded
- NNBR 1980
- SGMO 1995
- Country
- NNBR United States
- SGMO United States
- Employees
- NNBR N/A
- SGMO N/A
- Industry
- NNBR Industrial Machinery/Components
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NNBR Industrials
- SGMO Health Care
- Exchange
- NNBR Nasdaq
- SGMO Nasdaq
- Market Cap
- NNBR 109.1M
- SGMO 122.8M
- IPO Year
- NNBR 1994
- SGMO 2000
- Fundamental
- Price
- NNBR $1.97
- SGMO $0.70
- Analyst Decision
- NNBR
- SGMO Strong Buy
- Analyst Count
- NNBR 0
- SGMO 7
- Target Price
- NNBR N/A
- SGMO $5.29
- AVG Volume (30 Days)
- NNBR 86.9K
- SGMO 5.6M
- Earning Date
- NNBR 10-29-2025
- SGMO 11-11-2025
- Dividend Yield
- NNBR N/A
- SGMO N/A
- EPS Growth
- NNBR N/A
- SGMO N/A
- EPS
- NNBR N/A
- SGMO N/A
- Revenue
- NNBR $433,709,000.00
- SGMO $81,706,000.00
- Revenue This Year
- NNBR N/A
- SGMO $28.47
- Revenue Next Year
- NNBR $4.88
- SGMO N/A
- P/E Ratio
- NNBR N/A
- SGMO N/A
- Revenue Growth
- NNBR N/A
- SGMO 565.52
- 52 Week Low
- NNBR $1.58
- SGMO $0.41
- 52 Week High
- NNBR $4.67
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- NNBR 34.86
- SGMO 65.62
- Support Level
- NNBR $1.93
- SGMO $0.65
- Resistance Level
- NNBR $2.10
- SGMO $0.73
- Average True Range (ATR)
- NNBR 0.11
- SGMO 0.06
- MACD
- NNBR -0.03
- SGMO 0.01
- Stochastic Oscillator
- NNBR 10.47
- SGMO 68.98
About NNBR NN Inc.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.